M10.16
Lead-induced gout, knee
Clinical Classification Guidelines
Medical Intelligence & Overview
Lead-induced gout of the knee is a type of gout caused by exposure to lead, which leads to the accumulation of uric acid crystals in the knee joint. This condition can cause pain, swelling, and limited movement in the affected knee. It's a specific form of gout linked to lead poisoning, and understanding its causes, symptoms, diagnosis, and management is essential for affected individuals.
Causes & Symptoms
Clinical Causes: Prolonged or high-level exposure to lead, often through occupational exposure Chronic lead poisoning leading to interference with uric acid metabolism Environmental exposure via contaminated water, soil, or dust Use of lead-containing products or medications
Key Symptoms: Intense pain in the affected knee, often sudden Swelling and redness around the knee joint Stiffness and difficulty in moving the knee Presence of tophi (urate crystal deposits) around the joint Possible signs of systemic lead poisoning, such as fatigue, abdominal pain, or neurocognitive symptoms
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation, laboratory tests, and imaging studies. Key steps include: - Medical history assessment focusing on lead exposure - Blood lead level testing to confirm lead poisoning - Joint aspiration to analyze synovial fluid for uric acid crystals - Blood tests to measure uric acid levels - Imaging studies like X-ray or ultrasound to detect joint damage or tophi The distinguishing factor for lead-induced gout is the history of lead exposure coupled with biochemical evidence of lead poisoning and gout symptoms.
Treatment Protocols: Managing lead-induced gout of the knee involves a multi-faceted approach: - Removal or reduction of lead exposure to prevent further poisoning - Chelation therapy to eliminate excess lead from the body - Medications to control gout symptoms, such as nonsteroidal anti-inflammatory drugs (NSAIDs) or colchicine - Lifestyle modifications, including dietary changes to reduce uric acid levels - Monitoring of blood lead and uric acid levels to assess treatment effectiveness - In some cases, joint aspiration or surgical intervention may be necessary to remove tophi or relieve severe joint damage - Addressing systemic effects of lead poisoning through appropriate medical interventions Consultation with healthcare professionals specializing in toxicology and rheumatology is essential for tailored treatment plans and optimal patient care.
Clinical Advice & FAQs
Billing Guidance
Is M10.16 a billable ICD-10 code?
Yes, M10.16 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.16?
Clinical documentation must specify the nature of Lead-induced gout, knee and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
